Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance

Experimental Cell Research

Volumn 326, Issue 1, 2014, Pages 22-35

  Yang, Wei ^a   Wei, Jing ^a   Guo, Tiantian ^a   Shen, Yueming ^a   Liu, Fenju ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Glioma stem cells; Hypoxia; MIR 210; MNT; Radiosensitivity

Indexed keywords

CASPASE 3; CASPASE 7; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTIC ACID; MESSENGER RNA; MICRORNA 210; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; GENE TARGETING; GENE TRANSFER; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPOXIC CELL; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY;

GLIOMA STEM CELLS; HYPOXIA; MIR-210; MNT; RADIOSENSITIVITY;

ANOXIA; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MICRORNAS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84904282718     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.05.022     Document Type: Article

References (49)

1. Wen P., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
2. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
3. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
4. Beier D., Hau P., Proescholdt M., et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67:4010-4015.
5. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
6. Bao S., Wu Q., McLendon R.E., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
7. Ciceroni C., Bonelli M., Mastrantoni E., et al. Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas. Cell Death Differ. 2013, 20:396-407.
8. Calabrese C., Poppleton H., Kocak M., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
9. Ricci-Vitiani L., Pallini R., Biffoni M., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
10. Pistollato F., Abbadi S., Rampazzo E., et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 2010, 28:851-862.
11. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8:3274-3284.
12. McCord A.M., Jamal M., Shankavarum U.T., Lang F.F., Camphausen K., Tofilon P.J. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol. Cancer Res. 2009, 7:489-497.
13. Bar E.E., Lin A., Mahairaki V., Matsui W., Eberhart C.G. Hypoxia increases the expression of stem cell markers and promotes clonogenicity in glioblastoma neurospheres. Am. J. Pathol. 2010, 177:1491-1502.
14. Keith B., Johnson R.S., Simon M.C. HIF1α and HIF2α: sibling rivalry in hypoxic tumor growth and progression. Nat. Rev. Cancer 2011, 12:9-22.
15. Li Z., Bao S., Wu Q., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
16. Srinivasan S., Selvan S.T., Archunan G., Gulyas B., Padmanabhan P. MicroRNAs-the next generation therapeutic targets in human diseases. Theranostics 2013, 3:930-942.
17. Crosby M.E., Devlin C.M., Glazer P.M., Calin G.A., Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr. Pharm. Des. 2009, 15:3861-3866.
18. Huang X., Ding L., Bennewith K.L., et al. Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 2009, 35:856-867.
19. Kulshreshtha R., Ferracin M., Negrini M., Calin G.A., Davuluri R.V., Ivan M. Regulation of microRNA expression: the Hypoxic Component. Cell Cycle 2007, 6:1426-1431.
20. Zhang Z., Sun H., Dai H.Y., et al. MicroRNA miR-210 modulates cellular response to hypoxia through the Myc antagonist MNT. Cell Cycle 2009, 8:2756-2768.
21. Chan S.Y., Zhang Y.Y., Hemann C., Mahoney C.E., Zweier J.L., Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009, 10:273-284.
22. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M.C., Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
23. Kim H.W., Haider H.K., Jiang S., Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 2009, 284:33161-33168.
24. Kim J.H., Park S.G., Song S.Y., Kim J.K., Sung J.H. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis. 2013, 4:e588.
25. Liu Y., Han Y., Zhang H., et al. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS One 2012, 7:e52280.
26. Hong L., Han Y., Zhang H., Zhao Q., Qiao Y. miR-210: a therapeutic target in cancer. Expert Opin. Ther. Targets 2013, 17:21-28.
27. Yang W., Sun T., Cao J., Liu F.J., Tian Y., Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp. Cell Res. 2012, 318:944-954.
28. Grosso S., Doyen J., Parks S.K., et al. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis. 2013, 4:e544.
29. Hurlin P.J., Queva C., Eisenman R.N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 1997, 11:44-58.
30. Hurlin P.J., Huang J. The MAX-interacting transcription factor network. Semin. Cancer Biol. 2006, 16:265-274.
31. Timothy J.K., Amanda L.S., Clary B.C., Pere P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1α stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol. Cell Biol. 2011, 31:2696-2706.
32. Wang J., Wang H., Li Z., et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE 2008, 3:e3769.
33. Kulshreshtha R., Ferracin M., Wojcik S.E., et al. A microRNA signature of hypoxia. Mol. Cell Biol. 2007, 27:1859-1867.
34. Huang X., Le Q.T., Giaccia A.J. MiR-210-micromanager of the hypoxia pathway. Trends Mol. Med. 2010, 16:230-237.
35. Chan Y.C., Banerjee J., Choi S.Y., Sen C.K. miR-210: the master hypoxamir. Microcirculation 2012, 19:215-223.
36. Mutharasan R.K., Nagpal V., Ichikawa Y., Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am. J. Physiol.: Heart Circ. Physiol. 2011, 301:H1519-H1530.
37. Gordan J.D., Bertovrt J.A., Hu C.J., Diehl J.A., Simon M.C. HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell 2007, 11:335-347.
38. Nilsson J.A., Maclean K.H., Keller U.B., Pendeville H., Baudino T.A., Cleveland J.L. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol. Cell Biol. 2004, 24:1560-1569.
39. Murphy M.J., Wilson A., Trumpp A. More than just proliferation: myc function in stem cells. Trends Cell Biol. 2005, 15:128-137.
40. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344.
41. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
42. Ying Q., Liang L., Guo W., Zha R., Tian Q., Huang S. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 2011, 54:2064-2075.
43. Chen Z., Li Y., Zhang H., Huang P., Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29:4362-4368.
44. Puissegur M.P., Mazure N.M., Bertero T., et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 2011, 18:465-478.
45. Favaro E., Ramachandran A., McCormick R., et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 2010, 5:e10345.
46. Groussard C., Morel I., Chevanne M., Monnier M., Cillard J., Delamarche A. Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. J. Appl. Physiol. 2000, 89:169-175.
47. Sattler U.G., Meyer S.S., Quennet V., et al. Glycolytic metabolism and tumour response to fractionated irradiation. Radiother. Oncol. 2010, 94:102-109.
48. Sattler U.G., Mueller-Klieser W. The anti-oxidant capacity of tumour glycolysis. Int. J. Radiat. Biol. 2009, 85:963-971.
49. Crosby M.E., Kulshreshtha R., Ivan M., Glazer P.M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 2009, 69:1221-1229.